About 7 results found for searched term "65-85-0" (0.059 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2306 | Tideglusib | GSK-3 |
| NP-12; NP031112 | ||
| Tideglusib (NP031112, NP-12) is a potent non ATP-competitive inhibitor of GSK3 with IC50 of 60 nM. | ||
| M2443 | Benzoic Acid | Metabolite/Endogenous Metabolite |
| Benzoic acid is a colorless crystalline solid and a simple aromatic carboxylic acid, used as a food preservative. Benzoic acid is an aromatic alcohol existing naturally in many plants and is a common additive to food, drinks, cosmetics and other products. It acts as preservatives through inhibiting both bacteria and fungi. | ||
| M16265 | Peucedanol 7-O-glucoside | Coumarins |
| Peucedanol 7-O-glucoside | ||
| M24900 | Orilanolimab | Others |
| SYNT001; ALXN1830 | ||
| Orilanolimab (SYNT001) is a humanized, de-immunized and FcRn-blocking monoclonal antibody. Orilanolimab blocks the interaction between FcRn and the Fc portion of IgG molecules. Orilanolimab impedes IgG IC activation of the FcRn-mediated adaptive immune function. And Orilanolimab disrupts the associated pathways related to IgG homeostasis and innate and adaptive immunity. | ||
| M28781 | Trimetrexate trihydrochloride | Dihydrofolate reductase |
| CI-898 trihydrochloride | ||
| Trimetrexate (CI-898) trihydrochloride is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR. | ||
| M30433 | Cefmenoxime | Antibiotic |
| SCE-1365 | ||
| Cefmenoxime (SCE-1365) is a new semisynthetic cephalosporin antibiotic. Cefmenoxime has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. | ||
| M41410 | ATM Inhibitor-6 | ATM/ATR |
| ATM inhibitor-6 (A-193) is a selective ATM kinase inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
